|
HomeClinical Trials
Finding and Understanding Clinical TrialsA clinical study examines the effectiveness of new treatments and provides doctors and researchers with data to develop and deliver new, more effective treatments. In a typical year, over one million people participate in clinical studies.This site provides essential clinical trial information: how medical trials work; your rights as a participant; and learn how signing up for trials can provide access to the best medical facilities and specialists. Participate in a clinical study and you'll help not only yourself, but also the thousands of others who could benefit from the trial's results. Find a Trial... You can use this site to find clinical trials by location or by medical condition; see below. Also, by using the search box on the right of this page, you can narrow your search to zip code level. Current Clinical Trial Listings:Search results for Amyloidosis AND Recruiting1) Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL AmyloidosisAmyloidosis 2) Study of Systemic Amyloidosis Presentation and Prognosis Amyloidosis 3) Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-Diagnosed Light-Chain (AL)-Amyloidosis Amyloidosis 4) The Effect of Diflunisal on Familial Amyloidosis Familial Amyloid Polyneuropathy; Familial Amyloidosis 5) The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis Transthyretin-Associated Amyloidosis With Polyneuropathy 6) Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS) TTR-Associated Amyloidosis 7) High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis Multiple Myeloma and Plasma Cell Neoplasm 8) Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden Multiple Myeloma; Primary Amyloidosis 9) Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis Multiple Myeloma and Plasma Cell Neoplasm 10) Open-Label Phase 1/2 Study of VELCADE (Bortezomib) for Injection in Patients With Light-Chain (AL)-Amyloidosis Amyloidosis 11) Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Multiple Myeloma and Plasma Cell Neoplasm 12) Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction Multiple Myeloma and Plasma Cell Neoplasm 13) Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Multiple Myeloma and Plasma Cell Neoplasm 14) Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease Multiple Myeloma and Plasma Cell Neoplasm 15) Second Autologous Stem Cell Transplant in Treating Patients With Persistent or Recurrent Primary Systemic (AL) Amyloidosis Multiple Myeloma and Plasma Cell Neoplasm 16) Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Multiple Myeloma and Plasma Cell Neoplasm 17) The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With V122I or Wild-Type (Transthyretin) TTR Amyloid Cardiomyopathy Cardiomyopathy 18) High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors Childhood Germ Cell Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Neuroblastoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific 19) Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Unspecified Adult Solid Tumor, Protocol Specific 20) Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Pain; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol Specific |
|
Related Products and Services
